Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • BioTech • Hardware (& Manufacturing) • Energy • A.I. (& Big Data) • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Consumer • Pharmaceutical (& Medicine) • Woman Focused |
Stages | Pre-Seed, Seed, Series A, Series B |
Investing | United States |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Buff Gold Ventures is a venture capital firm that focuses on elevating innovative startups from diverse industries, specifically prioritizing University of Colorado entrepreneurs. They have established a formal partnership with Venture Partners at CU Boulder to source the best investment opportunities from their pipeline. Buff Gold Ventures invests across various sectors that include Software (Web Marketplace Saas, etc.), BioTech, Hardware (& Manufacturing), Energy, A.I. (& Big Data), HealthTech (& Fitness), Material Science, Medical Devices (& Hospital Services), DeepTech, Healthcare (& Wellness), Consumer, and Pharmaceutical (& Medicine), with a unique emphasis on companies rooted in disruptive technologies that address large problems. Their investment criteria are centered around CU founders—whether faculty or students—and companies licensing CU Intellectual Property. With their comprehensive investment approach, they not only inject capital at the Pre-Seed, Seed, Series A, and Series B stages but also provide follow-on capital and assist with syndication. Buff Gold Ventures is actively involved with their portfolio companies early on, working closely to build successful teams. Their investment amounts range from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot investment of approximately $1,500,000. Key examples of their portfolio include innovations in ferroelectric nematic liquid crystals, treatments for chronic rhinosinusitis, dynamic tinting windows, microbial systems for pharmaceutical development, advances in volumetric 3D printing, low-cost emission detection networks, and novel vaccine delivery platforms. The success of their portfolio companies aims to provide strong capital appreciation to their partners.